Urgent

Anticoagulation & thrombolysis in critical care

Clotting drugs · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Heparins: UFH (titratable, APTT-monitored, reversible with protamine — the ICU choice in renal failure/bleeding risk), LMWH (predictable, anti-Xa monitoring in renal failure/extremes of weight). Citrate for circuit anticoagulation in CRRT. Direct agents (dabigatran/rivaroxaban etc.) — know the reversal (idarucizumab; andexanet/PCC). Thrombolytics (alteplase/tenecteplase) for STEMI without PCI access, massive PE with shock, and selected stroke.

Red flags

  • Falling platelets on heparin is HIT until scored otherwise — thrombosis, not bleeding, is its killer
  • Thrombolysis contraindications are relative when the alternative is death — senior decision, documented

Management

  • Every ICU patient gets VTE prophylaxis ASSESSED daily — LMWH unless contraindicated, mechanical if bleeding risk
  • HIT: platelets falling >50% at day 5–10 on heparin ± thrombosis — 4T score, STOP all heparin (including flushes), start argatroban/danaparoid, never wait for the assay in high suspicion
  • Bleeding on anticoagulation: stop drug, give the antidote (protamine/vitamin K + PCC for warfarin/idarucizumab for dabigatran), local control, and re-plan
  • Thrombolysis in arrest for suspected massive PE: give and continue CPR 60–90 min
  • Peri-procedure: time neuraxial/line removal to LMWH dosing (12–24 h windows)

Drugs & doses

UFH 80 U/kg bolus then 18 U/kg/h, APTT ratio 1.5–2.5 (or anti-Xa)
Enoxaparin 1 mg/kg bd treatment / 40 mg od prophylaxis (adjust renal)
Protamine 1 mg per 100 U recent UFH (slow IV — hypotension/anaphylactoid)
Alteplase: massive PE 10 mg bolus + 90 mg/2 h (arrest: 50 mg bolus)
Regional citrate for CRRT per protocol (monitor ionised Ca²⁺)

Prophylaxis for everyone assessed daily; UFH when you need an off-switch; and respect HIT.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.